Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines - Multi-country assessment.

Weibel D, Sturkenboom M, Black S, de Ridder M, Dodd C, Bonhoeffer J, Vanrolleghem A, van der Maas N, Lammers GJ, Overeem S, Gentile A, Giglio N, Castellano V, Kwong JC, Murray BJ, Cauch-Dudek K, Juhasz D, Campitelli M, Datta AN, Kallweit U, Huang WT, Huang YS, Hsu CY, Chen HC, Giner-Soriano M, Morros R, Gaig C, Tió E, Perez-Vilar S, Diez-Domingo J, Puertas FJ, Svenson LW, Mahmud SM, Carleton B, Naus M, Arnheim-Dahlström L, Pedersen L, DeStefano F, Shimabukuro TT.

Vaccine. 2018 Oct 1;36(41):6202-6211. doi: 10.1016/j.vaccine.2018.08.008. Epub 2018 Aug 16.

2.

Diabetes self-management education is not associated with a reduction in long-term diabetes complications: an effectiveness study in an elderly population.

Shah BR, Hwee J, Cauch-Dudek K, Ng R, Victor JC.

J Eval Clin Pract. 2015 Aug;21(4):656-61. doi: 10.1111/jep.12360. Epub 2015 Apr 2.

PMID:
25847059
3.

Diabetes education through group classes leads to better care and outcomes than individual counselling in adults: a population-based cohort study.

Hwee J, Cauch-Dudek K, Victor JC, Ng R, Shah BR.

Can J Public Health. 2014 May 9;105(3):e192-7.

PMID:
25165838
4.

Utilization of Diabetes Education Centres in Ontario by people without diabetes.

Hwee J, Cauch-Dudek K, Victor JC, Ng R, Shah BR.

Can J Diabetes. 2014 Jun;38(3):186-90. doi: 10.1016/j.jcjd.2013.10.002.

PMID:
24909089
5.

Disparities in attendance at diabetes self-management education programs after diagnosis in Ontario, Canada: a cohort study.

Cauch-Dudek K, Victor JC, Sigmond M, Shah BR.

BMC Public Health. 2013 Jan 30;13:85. doi: 10.1186/1471-2458-13-85.

6.

Absence of disparities in the quality of primary diabetes care for South Asians and Chinese in an urban Canadian setting.

Shah BR, Cauch-Dudek K, Anand SS, Austin PC, Manuel DG, Hux JE.

Diabetes Care. 2012 Apr;35(4):794-6. doi: 10.2337/dc11-1845. Epub 2012 Feb 8.

7.

Diabetes prevalence and care in the Metis population of Ontario, Canada.

Shah BR, Cauch-Dudek K, Pigeau L.

Diabetes Care. 2011 Dec;34(12):2555-6. doi: 10.2337/dc11-0945. Epub 2011 Oct 12.

8.

The impact of diabetes education on blood glucose self-monitoring among older adults.

Millar A, Cauch-Dudek K, Shah BR.

J Eval Clin Pract. 2010 Aug;16(4):790-3. doi: 10.1111/j.1365-2753.2009.01195.x. Epub 2010 Jun 14.

PMID:
20557415
9.

Comparison of primary care physician payment models in the management of hypertension.

Tu K, Cauch-Dudek K, Chen Z.

Can Fam Physician. 2009 Jul;55(7):719-27.

10.

Validation of a health administrative data algorithm for assessing the epidemiology of diabetes in Canadian children.

Guttmann A, Nakhla M, Henderson M, To T, Daneman D, Cauch-Dudek K, Wang X, Lam K, Hux J.

Pediatr Diabetes. 2010 Mar;11(2):122-8. doi: 10.1111/j.1399-5448.2009.00539.x. Epub 2009 Jun 5.

PMID:
19500278
11.

Diabetes quality of care in academic endocrinology practice: a descriptive study.

Shah BR, James JE, Lawton C, Montada-Atin T, Sigmond M, Cauch-Dudek K, Booth GL.

Can J Diabetes. 2009;33(3):150-5. doi: 10.1016/S1499-2671(09)33005-1. Epub 2012 Dec 10.

PMID:
25998589
12.

Administrative data algorithms can describe ambulatory physician utilization.

Shah BR, Hux JE, Laupacis A, Zinman B, Cauch-Dudek K, Booth GL.

Health Serv Res. 2007 Aug;42(4):1783-96.

13.

Accuracy of administrative databases in identifying patients with hypertension.

Tu K, Campbell NR, Chen ZL, Cauch-Dudek KJ, McAlister FA.

Open Med. 2007 Apr 14;1(1):e18-26.

14.

Antimitochondrial antibody profiles: are they valid prognostic indicators in primary biliary cirrhosis?

Joshi S, Cauch-Dudek K, Heathcote EJ, Lindor K, Jorgensen R, Klein R.

Am J Gastroenterol. 2002 Apr;97(4):999-1002.

PMID:
12003438
15.

Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid.

Joshi S, Cauch-Dudek K, Wanless IR, Lindor KD, Jorgensen R, Batts K, Heathcote EJ.

Hepatology. 2002 Feb;35(2):409-13.

PMID:
11826416
16.

Human leukocyte antigen Class II associations in serum antimitochondrial antibodies (AMA)-positive and AMA-negative primary biliary cirrhosis.

Stone J, Wade JA, Cauch-Dudek K, Ng C, Lindor KD, Heathcote EJ.

J Hepatol. 2002 Jan;36(1):8-13.

PMID:
11804658
17.

Prevalence of IgA antibodies to endomysium and tissue transglutaminase in primary biliary cirrhosis.

Gillett HR, Cauch-Dudek K, Jenny E, Heathcote EJ, Freeman HJ.

Can J Gastroenterol. 2000 Sep;14(8):672-5.

PMID:
11185531
18.

Are antibodies to carbonic anhydrase II specific for anti-mitochondrial antibody-negative primary biliary cirrhosis?

Comay D, Cauch-Dudek K, Hemphill D, Diamandis E, Wanless I, Heathcote EJ.

Dig Dis Sci. 2000 Oct;45(10):2018-21.

PMID:
11117577
19.

Vitamin D-receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis.

Springer JE, Cole DE, Rubin LA, Cauch-Dudek K, Harewood L, Evrovski J, Peltekova VD, Heathcote EJ.

Gastroenterology. 2000 Jan;118(1):145-51.

PMID:
10611163
20.

Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis.

Heathcote EJ, Stone J, Cauch-Dudek K, Poupon R, Chazouilleres O, Lindor KD, Petz J, Dickson ER, Poupon RE.

Liver Transpl Surg. 1999 Jul;5(4):269-74.

21.

Asymptomatic primary biliary cirrhosis: a study of its natural history and prognosis.

Springer J, Cauch-Dudek K, O'Rourke K, Wanless IR, Heathcote EJ.

Am J Gastroenterol. 1999 Jan;94(1):47-53.

PMID:
9934730
22.

Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis.

Pasha T, Heathcote J, Gabriel S, Cauch-Dudek K, Jorgensen R, Therneau T, Dickson ER, Lindor KD.

Hepatology. 1999 Jan;29(1):21-6.

PMID:
9862844
23.

Fatigue in primary biliary cirrhosis.

Cauch-Dudek K, Abbey S, Stewart DE, Heathcote EJ.

Gut. 1998 Nov;43(5):705-10.

24.
25.

Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis.

Poupon RE, Lindor KD, Cauch-Dudek K, Dickson ER, Poupon R, Heathcote EJ.

Gastroenterology. 1997 Sep;113(3):884-90.

PMID:
9287980
26.

The professional lives of women in gastroenterology: a Canadian comparison study with men.

Heathcote J, Cauch-Dudek K, Rhyne D.

Gastroenterology. 1997 Aug;113(2):669-74.

PMID:
9247490
27.

Primary biliary cirrhosis, sicca complex, and dysphagia.

Mang FW, Michieletti P, O'Rourke K, Cauch-Dudek K, Diamant N, Bookman A, Heathcote J.

Dysphagia. 1997 Summer;12(3):167-70.

PMID:
9190103
28.

Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?

Kilmurry MR, Heathcote EJ, Cauch-Dudek K, O'Rourke K, Bailey RJ, Blendis LM, Ghent CN, Minuk GY, Pappas SC, Scully LJ, Steinbrecher UP, Sutherland LR, Williams CN, Worobetz LJ.

Hepatology. 1996 May;23(5):1148-53.

PMID:
8621147
29.

The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.

Heathcote EJ, Cauch-Dudek K, Walker V, Bailey RJ, Blendis LM, Ghent CN, Michieletti P, Minuk GY, Pappas SC, Scully LJ, et al.

Hepatology. 1994 May;19(5):1149-56.

PMID:
8175136

Supplemental Content

Loading ...
Support Center